Sorry, you need to enable JavaScript to visit this website.

This site is intended only for healthcare professionals resident in the United Kingdom

Resistance mechanisms and outbreaks

This promotional meeting is organised and funded by Pfizer and may include reference to Pfizer medicines relevant to agenda topics.

  • Bacterial Topic

Resistance mechanisms and outbreaks

Date: 13th October & 15th October

Time: 12pm - 13th October 
            6pm - 15th October 

Duration: 1 hour

Additional details: This is a live webinar. A live Q&A with the speakers will be available. 

Register Here

About the webinar

This webinar is a promotional meeting that will focus on:
•    An overview of the Gram-negative resistance landscape globally and in UK
•    Sharing experience of managing OXA-48 outbreaks in the UK including the importance of avoiding these outbreaks through effective AMS
•    RWD on use of Zavicefta® (ceftazidime avibactam) in infections due to OXA-48
•    Sharing experience of managing ESBL resistance mechanisms
•    The importance of early adequate therapy in ICU

About the speakers

Dr David Jenkins
Consultant Medical Microbiologist and Lead Infection Control Doctor, 
University Hospital of Leicester NHS Trust and Honorary Reader, 
University of Leicester

Dr Mahableshwar Albur
Consultant in Infection and Microbiology,
North Bristol NHS Trust

This meeting is organised & funded by Pfizer Ltd. Please note that, under the law and the ABPI Code of Practice, Pfizer may only promote its medicines and provide hospitality to members of the healthcare professions and other relevant decision makers. Therefore, no unqualified person (e.g. medical students, non-medical spouses/partners/family members) may be invited to or attend Pfizer promotional meetings. 

 

Prescribing information 

Zavicefta (ceftazidime avibactam)
ZAVICEFTA® 2 g/0.5 g Powder for Concentrate for Solution for Infusion – SPC
Legal category: POM. Basic NHS price: 10 vial pack £857.00.